CRISPR Therapeutics
Tracked across 1 events · 11 articles · First seen Feb 11, 2026 · Last active Feb 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
CRISPR Therapeutics is developing a gene-editing approach targeting the ANGPTL3 gene, which has shown promising results in early-stage trials by significantly lowering LDL and triglyceride levels. This could lead to a permanent solution for high cholesterol.
Feb 11, 2026 · 11 articles
NEWSDESK
Track CRISPR Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard